Hospital Quironsalud Barcelona — Clinical Trial Site

147 Registered trials

55 Currently recruiting

Organisation

Hospital Quironsalud Barcelona

Location

Barcelona, Spain

Identifier

ORG-100042252

Address

Placa D'alfonso Comin 5-7, 08023, Spain

Departments

-
#3309: Oncology
#3457: Medicina Interna
2805: Medicina Interna
3131: medicina interna
34005: Next Oncology. Phase I Unit
Breast and skin cancer Unit
Departamento de Ginecología
Endocrinología
Endocrinology
Institute of Oncology Barcelona
Instituto de Oncología de Barcelona
Internal Medicine
IOB Institute of Oncology
Medical Oncologist
Medical Oncology
Medical Oncology Department
Medical Oncology, Phase I unit Next Oncology
Medicina Interna
N/A
Next Oncology
Next Oncology Barcelona
Next Oncology Barcelona IOB
NEXT Oncology Phase I unit - IOB Hospital Quironsalud Barcelona
Next Oncology. IOB
Next Oncology. Phase I Unit. IOB - Hospital Quironsalud Barcelona
Oncología
Oncología Médica
Oncología Médica. Unidad NEXT Oncology
Oncology
Oncology - Phase I Unit
Oncology Department
Oncology Medical Service
Oncology Service
Pediatria
Phase I Unit
Phase I Unit - NEXT Oncology Barcelona
Phase Unit I
Rheumatology
Servicio de Medicina Interna
Servicio de Oncologia
Servicio de Oncología - NEXT Oncology
Unidad de cancer genitourinario
Unidad de Ensayos Fase I
Unidad Ensayos Fase I - Oncology

Clinical trials at this site (147)

Search interface

A study to test if different doses of D3S-001 used on its own or in combination with other anti-cancer medicines is safe and tolerable in pe… Recruiting

2023-508517-16-00 Advanced Solid Tumors with a KRAS p.G12C Mutation 7 2024-11-10
Phase 1/2 study testing for the first time in humans a novel drug, STAR0602, to selectively stimulate T cells for the treatment of subjects … Recruiting

2023-505334-10-01 Unresectable, Locally Advanced, or Metastatic Solid Tum 7 2024-10-30
A Study to Investigate the Safety and Efficacy of KQB198 as Monotherapy and in Combination in Participants with Advanced Solid Malignancies Recruiting

2024-511453-22-00 Participants with Advanced Solid Malignancies 1 2024-10-28
A study to test whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure. Recruiting

2023-509706-30-00 Heart failure (HF) 5 2024-10-18
Comparison between ABP 234 and Keytruda® (Pembrolizumab) Recruiting

2024-514304-14-00 Advanced or Metastatic Non-squamous Non-Small Cell Lung 1 2024-10-08
A clinical trial to learn about the safety and effects of STX-241, a new oral anticancer drug for the treatment of patients with advanced lu… Recruiting

2023-510203-21-00 locally advanced or metastatic non-small cell lung canc 7 2024-09-24
HARMONi-3 Recruiting

2024-513087-26-00 Metastatic Non-small Cell Lung Cancer 5 2024-09-10
First-in-Human Study of OKI-219 Alone and in Combination with Other Therapies in Patients with Solid Tumors / Breast Cancer Recruiting

2023-508435-31-00 Advanced Solid Tumors, Advanced Breast Cancer 1 2024-08-09
A Phase 3 study of Dostarlimab as Sequential Therapy after Chemoradiation compared to placebo in adult participants with Locally Advanced Un… Recruiting

2023-508613-17-00 Neoplasms, Head and Neck 5 2024-05-29
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a p53 Y220C Mutation (PYNNACLE) Recruiting

2023-504251-27-00 Locally Advanced or Metastatic Solid Tumors Harboring a 7 2024-05-27
A study of ASP3082 in adults with advanced solid tumors Recruiting

2022-501590-39-00 Solid Tumor 1 2024-05-22
STUDY OF OP-1250 ADMINSTERED AS MONOTHERAPY AND COMPARED TO STANDARD OF CARE FOR THE TREATMENT OF ER+, HER2– ADVANCED OR METASTATIC BREAST C… Recruiting

2023-505871-63-00 ER+, HER2- metastatic breast cancer following endocrine 5 2024-04-08
First in Human Study of TOS-358 in Adults with Soid Tumors Recruiting

2023-505346-26-01 9 main solid tumors – colorectal, cervical, endometrial 7 2024-02-19
An Open-Label, Phase 2b, Global Multicenter Cohort Trial to Assess the Safety and Efficacy of Zipalertinib in Patients with Locally Advanced… Recruiting

2023-503865-48-00 Locally Advanced or Metastatic Non-Small Cell Lung Canc 4 2024-02-16
Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors Recruiting

2023-506604-18-00 Triple negative breast cancer 1 2024-02-14
A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors. Recruiting

2023-504807-94-00 Breast Cancer; Advanced solid tumors including but not 7 2023-12-26
Safety, pharmacokinetics, and preliminary efficacy of VIR-5500 (AMX-500) in prostate cancer Recruiting

2023-503495-24-00 Hormone-refractory prostate cancer 1 2023-10-30
Clinical study to test the safety, tolerance and preliminary efficacy of oral ITF3756 administered alone or in combination with an anti-prot… Recruiting

2022-501089-22-00 Advanced solid tumors 1 2022-11-29
A Phase 1 First-in-Human Study of the Safety and Effects of VIR-5818 Alone or with Pembrolizumab in Participants with Advanced or Metastatic… Recruiting

2024-516010-38-00 Participants with Locally Advanced or Metastatic HER2-E 1 2022-04-25
A First-in-Human Study to Evaluate the Safety and Anti-cancer Activity of the product FS222, which is an Antibody medication, in Subjects wi… Recruiting

2024-514010-12-00 Advanced Malignancies 1 2020-12-03
A Study of Sigvotatug Vedotin in Advanced Solid Tumors Recruiting

2023-508469-34-00 Esophageal cancer 1 2020-10-14
Study of Romiplostim for Chemotherapy-induced Thrombocytopenia in Adult Subjects With Non-small Cell Lung Cancer (NSCLC), Ovarian Cancer, or… Recruiting

2023-507149-27-00 Chemotherapy-induced Thrombocytopenia in Adult subjects 5 2019-11-04
Mevrometostat Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma Recruiting

2023-509179-18-00 Castration Resistant Prostate Cancer (CRPC) 1 2019-08-13
A study of S095035 as a single agent and in combination in adult participants with advanced or metastatic solid tumors with deletion of MTAP Ended

2025-521249-25-00 MTAP-deleted advanced or metastatic solid tumors 7 2025-10-30